Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05926050 · ClinicalTrials.gov registry record · NA
The Acute Effects of a Dietary Supplement on Cognitive Performance in Highly Trained Athletes.
A NA study of Reaction Time, sponsored by USANA Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT05926050 is a NA study of Reaction Time that has completed, run by USANA Health Sciences. The registered enrollment target is 41 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05926050, a NA study of Reaction Time, has completed, sponsored by USANA Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
This study was designed to determine if a dietary supplement containing extracts of American ginseng, bacopa monnieri and coffee fruit can enhance cognitive performance in a population of trained athletes.
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Treatment (CopaPrime+ (USANA Health Sciences)
Study Locations (1)
Utah
- US Ski and Snowboard Center of Excellence - Park City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2021-09-08 |
| Est. Completion | 2022-08-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05926050
The ClinicalTrials.gov registry entry for NCT05926050 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is USANA Health Sciences, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Reaction Time appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05926050 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT05926050 about?
NCT05926050 is a clinical study titled "The Acute Effects of a Dietary Supplement on Cognitive Performance in Highly Trained Athletes.". This study was designed to determine if a dietary supplement containing extracts of American ginseng, bacopa monnieri and coffee fruit can enhance cognitive performance in a population of trained athletes.
What is the current status of trial NCT05926050?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2021-09-08. Estimated completion is 2022-08-10.
What conditions does trial NCT05926050 study?
This clinical trial studies the following conditions: Reaction Time.
What interventions are being tested in trial NCT05926050?
The interventions under investigation include: Placebo (OTHER), Treatment (CopaPrime+ (USANA Health Sciences) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05926050?
This trial is sponsored by USANA Health Sciences, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05926050 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.